IFNA17 and depressive symptom measurement: While both EPA and DHA delayed the onset of IFN-α induced depression, only EPA significantly reduced the incidence rate compared to placebo (10% vs. 30%), suggesting that EPA, more so than DHA, might be efficacious in treating inflammatory depression.